BAINIAN YIHAO
Established in 2017, the 100-year nickname is positioned in the transformation of biomedical innovations and new drug research and development institutions, mainly for the development of new drugs such as CAR-T cell therapy and tumor vaccines, such as immunotherapy, gene therapy, stem cell therapy and small molecule targeted drugs. .
BAINIAN YIHAO
Industry:
Biotechnology Health Care Hospital Medical
Founded:
2017-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Total Employee:
51+
Status:
Active
Total Funding:
150 M CNY
Current Employees Featured
Investors List
Chengdu Tianfu International Bio-Town Investment & Development
Chengdu Tianfu International Bio-Town Investment & Development investment in Series A - Bainian Yihao
PKU V-Ming Investment
PKU V-Ming Investment investment in Series A - Bainian Yihao
DT Capital Partners
DT Capital Partners investment in Series A - Bainian Yihao
Canton Venture Capital
Canton Venture Capital investment in Series A - Bainian Yihao